Tuesday, May 30, 2017 8:38:38 AM
BALTIMORE, MD--(Marketwired - May 30, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that Ronald Marcus MD, Chief Medical Officer, will present at the American Society for Clinical Psychopharmacology Conference in Miami Beach on May 30th, 2017. The presentation is titled "A Clinical Development program in Psychiatry for a Selective Kappa Antagonist" and is focused on the results from a previously reported National Institute of Mental health of the National Institutes of Health sponsored proof-of concept study of CERC-501 in treatment resistant depression
History.htm
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM